Mirae Asset Flexi Cap Fund
The scheme seeks to provide long-term capital appreciation from a portfolio investing predominantly in Indian equity and equity related instruments across market capitalization.
Growthvine rating: 3/5 — ranked #16 of 52 in category.
Fund basics
| Category | Equity: Flexi Cap |
|---|
| NAV | ₹16.37 (as of 2026-08-21) |
|---|
| AUM | ₹4,262 Cr |
|---|
| Expense ratio | 1.62% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Varun Goel |
|---|
| Exit load | For units in excess of 15% of the investment, 1% will be charged for redemption within 1 year |
|---|
Performance & risk
| Sharpe ratio | 0.43 |
|---|
| Standard deviation | 14.29% |
|---|
| Max drawdown | -16.74% |
|---|
| Alpha | 0.47 |
|---|
| Beta | 0.93 |
|---|
Over 5 years, captured 93.2% of Nifty 500's upside and 92.6% of its downside.
Market cap allocation
| Large cap | 66.5% |
|---|
| Mid cap | 20.4% |
|---|
| Small cap | 13.0% |
|---|
Concentration
| Top 5 holdings | 20.5% |
|---|
| Top 10 holdings | 30.4% |
|---|
| Total holdings | 84 |
|---|
| Index overlap | 49.8% |
|---|
| Active share | 50.2% |
|---|
Top holdings
- ICICI Bank Ltd. — 5.8%
- HDFC Bank Ltd. — 5.6%
- Reliance Industries Ltd — 4.2%
- State Bank Of India — 2.6%
- Bharti Airtel Ltd. — 2.3%
- AXIS Bank Ltd. — 2.3%
- Larsen & Toubro Limited — 2.0%
- Infosys Ltd — 1.9%
- Mahindra & Mahindra Ltd. — 1.9%
- Divis Laboratories Ltd. — 1.7%
Top sectors
- Banking & Financial — 23.3%
- Pharma & Biotech — 8.1%
- Automobile — 6.9%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | -0.8% | Q3 | #36 of 50 |
| 2025 | 8.9% | Q1 (Top) | #8 of 43 |
| 2024 | 17.3% | Q3 | #25 of 42 |